Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

Eligibility Criteria

• * Age 18 and older
• * Mild to severe plaque psoriasis (2% or greater Body Surface Area; Psoriasis Area and Severity Score of 2 or greater; Investigator Grade Assessment of mild-severe)
• * Currently taking medication that alters the normal ion balance of low-dose in blood.
• * No calcium supplements 1 month prior to baseline (not including multivitamins).
• * Unstable or uncontrolled illness, including but not limited to cerebro-cardiovascular, respiratory, hepatic, renal, gastrointestinal, endocrine, hematologic, neurologic or psychiatric disease at screening.
• * Abnormal laboratory values at screening, that in the opinion of the investigator, would potentially affect patient safety or data integrity.
• * Not on systemic non-biologic therapy (including, but not limited to, oral psoralen plus ultraviolet A \[photochemotherapy (PUVA)\] light therapy; cyclosporine; corticosteroids; methotrexate; oral retinoids; apremilast; tofacitinib; mycophenolate mofetil; thioguanine; hydroxyurea; sirolimus; tacrolimus; azathioprine; leflunomide; fumaric acid derivatives; or 1, 25 dihydroxy vitamin D3 and analogues) within 28 days prior to baseline.
• * No phototherapy (including either oral and topical PUVA light therapy, ultraviolet B, excimer laser, or self-treatment with tanning beds or therapeutic sunbathing) within 28 days prior to baseline.
• * No topical treatment (including, but not limited to, corticosteroids \[upper mid strength or lower potency topical steroids are permitted on the intertriginous areas and face\], crisaborole, anthralin, calcipotriene, topical vitamin D derivatives, retinoids, tazarotene, pimecrolimus, tacrolimus, emollients and other nonprescription topical products containing urea, \>3% salicylic acid, alpha- or beta-hydroxyl acids, or medicated shampoos \[for example those that contain \>3% salicylic acid, corticosteroids, coal tar, or vitamin D3 analogues\]) within 14 days prior to baseline.
• * No biologic agents within 8 weeks or three half-lives, whichever is greater prior to baseline.
• * History of renal impairment.
• * History of renal stones.
• * History of parathyroid abnormalities
• * Osteoporosis
• * History of severe arthritis
• * Ongoing use of tanning bed or other UV device or excessive sunlight
• * Unable to understand/complete informed consent.